Informe nº Osteba D12-04. - Euskadi.net

ESTRATEGIAS TERAPÉUTICAS EN LA ESQUIZOFRENIA REFRACTARIA O ESQUIZOFRENIA RESISTENTE AL TRATAMIENTO44. Robinson DG, Woerner MG, Alvir JM y cols.Predictors of treatment response from a firstepisode of schizophrenia or schizoafective disorder.Am J Psychiatry. 1999; 156: 544-549.45. Schooler NR, Keith SJ, Severe JB y cols. Relapseand rehospitalization during maintenencetreatment of schizophrenia: the effectsof dose reduction and family treatment. ArchivesGen Psychiatry. 1997; 54: 453-463.46. Schulz SC, Sinicrope P, Kishore P y cols. Treatmentresponse and ventricular brain enlargementin young schizophrenic patients.Psychopharm Bull. 1983: 19: 510-512.47. Seeman MV. Gender differences in schizophrenia:women vs. men. Can J Psychiatry. 1982;27: 108-111.48. Torrey EF, Bowler AE, Taylor EH y cols. Schizophreniaand Manic-Depressive Disorder.Nueva York: Basic Books; 1994. p.157.49. Van Horn JD, McManus IC. Ventricular enlargementin schizophrenia. A meta-analysisof studies on the ventricule:brain ratio(VBR). Br J Psychiatry. 1992; 160: 687-697.50. Weinberger DR, Bigelow LB, Kleiman JE y cols.Cerebral ventricle enlargement in chronicschizophrenia: association with poor responseto treatment. Arch Gen Psychiatry.1980; 37: 11-14.51. Wolkowitz OM, Breier A, Doran A y cols. Alprazolamaugmentation of the antipsychotic effectsof fluphenazine in schizophrenicpatients: preliminary results. Arch GenPsychiatry. 1988; 45: 664-671.52. Wyatt RJ. Neuroleptics and the natural courseof schizophrenia. Schizophr Bull. 1991; 17:325-351.32